What medications are used to treat Irritable Bowel Syndrome (IBS) in Canada?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for IBS in Canada

For IBS with constipation (IBS-C), start with polyethylene glycol or psyllium, then escalate to linaclotide 290 mcg once daily as the most effective second-line agent; for IBS with diarrhea (IBS-D), use loperamide first-line, then rifaximin or ondansetron; for abdominal pain across all subtypes, use antispasmodics initially, then low-dose tricyclic antidepressants (amitriptyline 10-30 mg at bedtime). 1, 2

IBS with Constipation (IBS-C)

First-Line Pharmacological Treatment

  • Osmotic laxatives (polyethylene glycol) should be initiated first, titrating the dose according to symptoms, with abdominal pain being the most common side effect 1, 2
  • Soluble fiber (psyllium/ispaghula) at 3-4 g/day is effective for global symptoms and abdominal pain, but must be increased gradually to avoid bloating and gas 1, 3, 2
  • Avoid insoluble fiber (wheat bran) as it consistently worsens IBS-C symptoms 1, 3

Second-Line Pharmacological Treatment

  • Linaclotide 290 mcg once daily is the most effective secretagogue available for IBS-C and should be the preferred second-line agent when first-line therapies fail, with studies conducted in Canada showing 30% reduction in abdominal pain and increased complete spontaneous bowel movements 1, 2
  • Lubiprostone 8 mcg twice daily (FDA-approved for IBS-C in women ≥18 years) is an alternative if linaclotide is not tolerated, with less likelihood of causing diarrhea than other secretagogues, though nausea is a frequent side effect 1, 3, 4, 2
  • Plecanatide 3 mg once daily is another guanylate cyclase-C agonist option, though diarrhea is a common side effect 1, 3
  • Tenapanor 50 mg twice daily is effective for IBS-C but availability in Canada may be limited 1

For Abdominal Pain in IBS-C

  • Antispasmodics with anticholinergic properties (dicyclomine) can be effective for abdominal pain and global symptoms, though dry mouth, visual disturbance, and dizziness are common side effects 1, 3, 5
  • Peppermint oil is effective for abdominal pain with gastroesophageal reflux being the main side effect 1, 3, 5

IBS with Diarrhea (IBS-D)

First-Line Pharmacological Treatment

  • Loperamide 2-4 mg up to four times daily is effective for controlling stool frequency, urgency, and fecal soiling, though it has limited effect on abdominal pain 1, 3, 2
  • Titrate loperamide carefully to avoid constipation, abdominal pain, and bloating 1, 2

Second-Line Pharmacological Treatment

  • Rifaximin 550 mg three times daily for 14 days is effective for IBS-D, though its effect on abdominal pain is limited 1, 3, 6, 2
  • 5-HT3 receptor antagonists (ondansetron) starting at 4 mg once daily and titrating to maximum 8 mg three times daily are highly efficacious for IBS-D 1, 3, 2
  • Eluxadoline (μ-opioid and κ-opioid receptor agonist) is effective for IBS-D but is contraindicated in patients with prior sphincter of Oddi problems, cholecystectomy, alcohol dependence, pancreatitis, or severe liver impairment 3, 2

Abdominal Pain Management Across All IBS Subtypes

First-Line for Pain

  • Antispasmodics (cimetropium, dicyclomine, hyoscine) are effective for abdominal pain, particularly when symptoms are exacerbated by meals 1, 3, 5
  • Peppermint oil is effective for abdominal pain and global symptoms 1, 3, 2, 5

Second-Line for Refractory Pain

  • Tricyclic antidepressants (amitriptyline) starting at 10 mg once daily at bedtime, titrated slowly to 30-50 mg daily, are the most effective treatment for refractory abdominal pain and global symptoms across all IBS subtypes 1, 3, 2, 5
  • TCAs should be continued for at least 6 months if the patient reports symptomatic response 1, 3
  • In IBS-C, use TCAs cautiously as they may worsen constipation; ensure adequate laxative therapy is in place 3
  • Selective serotonin reuptake inhibitors (SSRIs) may be effective as second-line neuromodulators for global symptoms when TCAs are not tolerated, though evidence quality is lower than for TCAs 1, 3, 5

IBS with Mixed Symptoms (IBS-M)

  • Tricyclic antidepressants (amitriptyline 10-30 mg once daily) are the most effective first-line pharmacological treatment for mixed IBS 3
  • Treat predominant symptoms with symptom-specific agents: loperamide for diarrhea episodes, osmotic laxatives for constipation episodes 3
  • Antispasmodics are effective for reducing abdominal pain in mixed IBS 3

Additional Therapies

Probiotics

  • A 12-week trial of probiotics may be effective for global symptoms and abdominal pain, though no specific strain can be recommended; discontinue if no improvement occurs 1, 2

Psychological Therapies for Refractory Symptoms

  • Cognitive-behavioral therapy specific for IBS and gut-directed hypnotherapy are effective when symptoms persist despite 12 months of pharmacological treatment 1, 3, 2

Critical Pitfalls to Avoid

  • Do not use loperamide as primary treatment for abdominal pain as it has limited effect on pain 1, 3
  • Avoid insoluble fiber (wheat bran) as it worsens symptoms 1, 3
  • Do not recommend gluten-free diets unless celiac disease is confirmed 1, 3, 2
  • Do not use IgG antibody-based food elimination diets as they lack evidence 3, 2
  • When prescribing TCAs or SSRIs, clearly explain they are being used for gut-brain modulation, not depression 1, 3
  • Lubiprostone should be taken with food and water to reduce nausea; patients should be aware of possible syncope and hypotension, particularly within the first hour after dosing 4
  • Rifaximin is not suitable for treating systemic bacterial infections due to limited systemic absorption 6
  • Manage patient expectations: complete symptom resolution is often not achievable; the goal is symptom relief and improved quality of life 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Alternatives to Amitriptyline for Irritable Bowel Syndrome (IBS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.